Long-term safety and efficacy of subcutaneous pasireotide in patients with Cushing’s disease: interim results from a long-term real-world evidence study

被引：0
|
作者：
Luca Manetti
Timo Deutschbein
Jochen Schopohl
Kevin C. J. Yuen
Michael Roughton
Ulrike Kriemler-Krahn
Libuse Tauchmanova
Ricardo Maamari
Carla Giordano
机构：
[1] Università di Pisa,Azienda Ospedaliero
[2] University of Würzburg,Universitaria Pisana, Dipartimento di Medicina Clinica e Sperimentale
[3] Ludwig-Maximilians-Universität München,Division of Endocrinology and Diabetes, Department of Internal Medicine I, University Hospital
[4] Swedish Neuroscience Institute,Medizinische Klinik und Poliklinik IV
[5] Barrow Neurological Institute,Swedish Pituitary Center
[6] Novartis Pharma AG,Section of Endocrinology, Diabetology and Metabolism, Department of Health Promotion Sciences Maternal and Infantile Care, Internal Medicine and Medical Specialities (PROMISE)
[7] Novartis Pharmaceuticals Corporation,undefined
[8] University of Palermo,undefined
来源：
Pituitary | 2019年 / 22卷
关键词：
Cushing’s disease; Pasireotide; Hypercortisolism; Pituitary; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：542 / 551
页数：9
相关论文
共 50 条
  • [1] Long-term safety and efficacy of subcutaneous pasireotide in patients with Cushing's disease: interim results from a long-term real-world evidence study
    Manetti, Luca
    Deutschbein, Timo
    Schopohl, Jochen
    Yuen, Kevin C. J.
    Roughton, Michael
    Kriemler-Krahn, Ulrike
    Tauchmanova, Libuse
    Maamari, Ricardo
    Giordano, Carla
    PITUITARY, 2019, 22 (05) : 542 - 551
  • [2] Long-term efficacy and safety of subcutaneous pasireotide alone or in combination with cabergoline in Cushing's disease
    Feelders, Richard A.
    Fleseriu, Maria
    Kadioglu, Pinar
    Bex, Marie
    Gonzalez-Devia, Deyanira
    Boguszewski, Cesar Luiz
    Yavuz, Dilek Gogas
    Patino, Heather
    Pedroncelli, Alberto M.
    Maamari, Ricardo
    Chattopadhyay, Arghya
    Biller, Beverly M. K.
    Pivonello, Rosario
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [3] Long-term efficacy and safety of osilodrostat in patients with Cushing's disease: results from the LINC 4 study extension
    Gadelha, Monica
    Snyder, Peter J.
    Witek, Przemyslaw
    Bex, Marie
    Belaya, Zhanna
    Turcu, Adina F.
    Feelders, Richard A.
    Heaney, Anthony P.
    Paul, Michaela
    Pedroncelli, Alberto M.
    Auchus, Richard J.
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [4] Long-term efficacy and safety of once-monthly pasireotide in Cushing's disease: A Phase III extension study
    Fleseriu, Maria
    Petersenn, Stephan
    Biller, Beverly M. K.
    Kadioglu, Pinar
    De Block, Christophe
    T'Sjoen, Guy
    Vantyghem, Marie-Christine
    Tauchmanova, Libuse
    Wojna, Judi
    Roughton, Michael
    Lacroix, Andre
    Newell-Price, John
    CLINICAL ENDOCRINOLOGY, 2019, 91 (06) : 776 - 785
  • [5] Long-term, real-world experience of pasireotide dose reduction in patients with acromegaly
    Marques, Nelma Veronica
    Wildemberg, Luiz Eduardo Armondi
    Gadelha, Monica R.
    ENDOCRINE CONNECTIONS, 2023, 12 (10)
  • [6] Long-term Efficacy and Safety of Pasireotide in Patients With Acromegaly: 14 Years of Single-Center Real-World Experience
    Gadelha, Monica
    Marques, Nelma Veronica
    Fialho, Christhiane
    Scaf, Cristiane
    Lamback, Elisa
    Antunes, Ximene
    Santos, Erica
    Magalhaes, Jaqueline
    Wildemberg, Luiz Eduardo
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (12): : E1561 - E1569
  • [7] LONG-TERM EFFICACY AND SAFETY OF RISANKIZUMAB: A RETROSPECTIVE, MULTICENTER, REAL-WORLD STUDY
    Kim, Han-Na
    Woo, Bin
    Kim, Young Chan
    Kim, Dai-Hyun
    Son, Sang Wook
    Baek, Yoo Sang
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [8] Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study
    Chaparro, Maria
    Baston-Rey, Iria
    Fernandez-Salgado, Estela
    Gonzalez Garcia, Javier
    Ramos, Laura
    Diz-Lois Palomares, Maria Teresa
    Arguelles-Arias, Federico
    Iglesias Flores, Eva
    Cabello, Mercedes
    Rubio Iturria, Saioa
    Nunez Ortiz, Andrea
    Charro, Mara
    Ginard, Daniel
    Duenas Sadornil, Carmen
    Merino Ochoa, Olga
    Busquets, David
    Iyo, Eduardo
    Gutierrez Casbas, Ana
    Ramirez de la Piscina, Patricia
    Maia Bosca-Watts, Marta
    Arroyo, Maite
    Jose Garcia, Maria
    Hinojosa, Esther
    Gordillo, Jordi
    Martinez Montiel, Pilar
    Velayos Jimenez, Benito
    Quilez Ivorra, Cristina
    Vazquez Moron, Juan Maria
    Maria Huguet, Jose
    Gonzalez-Lama, Yago
    Munagorri Santos, Ana Isabel
    Manuel Amo, Victor
    Dolores Martin-Arranz, Maria
    Bermejo, Fernando
    Martinez Cadilla, Jesus
    Rubin de Celix, Cristina
    Fradejas Salazar, Paola
    Lopez San Roman, Antonio
    Jimenez, Nuria
    Garcia Lopez, Santiago
    Figuerola, Anna
    Jimenez, Itxaso
    Martinez Cerezo, Francisco Jose
    Taxonera, Carlos
    Varela, Pilar
    de Francisco, Ruth
    Monfort, David
    Molina Arriero, Gema
    Hernandez Camba, Alejandro
    Javier Garcia-Alonso, Francisco
    INFLAMMATORY BOWEL DISEASES, 2022, 28 (11) : 1725 - 1736
  • [9] Long-term safety and effectiveness of adalimumab in 462 patients with intestinal Behcet's disease: Results from a real-world observational study
    Suzuki, Y.
    Hagiwara, T.
    Kobayashi, M.
    Morita, K.
    Shimamoto, T.
    Hibi, T.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S311 - S312
  • [10] Long-term efficacy and safety of tofacitinib in patients with ulcerative colitis: 3-year results from a real-world study
    Shimizu, Hiromichi
    Aonuma, Yuko
    Hibiya, Shuji
    Kawamoto, Ami
    Takenaka, Kento
    Fujii, Toshimitsu
    Saito, Eiko
    Nagahori, Masakazu
    Ohtsuka, Kazuo
    Okamoto, Ryuichi
    INTESTINAL RESEARCH, 2024, 22 (03) : 369 - 377
12345